|
ProBiotix Health PLC on Monday reported an improved third quarter and said it is ‘comfortably on track’ to meet its long-term aims. The Wakefield, England-based life sciences business reported a 30% year-on-year increase in third quarter sales to £2.0 million, from £1.5 million. Gross profit jumped 21% to £1.1 million from £874,000 a year prior. Chief Executive Officer Steen Andersen said: ‘The recent well received launch of new products, coupled with the sell through of products by our increasing number of worldwide distributors, augurs well for our future growth prospects. ‘Driven by the current momentum we remain comfortably on track to reach our long term strategic objectives, and look forward to providing further updates on our progress in the months ahead.’ OptiBiotix Health PLC is ProBiotix’s largest individual shareholder, owning just under 34% of ordinary shares in the company. Shares in Aquis-listed ProBiotix were up 11% to 7.50 pence in London on Monday afternoon. Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
